0001213900-23-094101.txt : 20231207
0001213900-23-094101.hdr.sgml : 20231207
20231207170008
ACCESSION NUMBER: 0001213900-23-094101
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20231207
DATE AS OF CHANGE: 20231207
EFFECTIVENESS DATE: 20231207
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Heart Test Laboratories, Inc.
CENTRAL INDEX KEY: 0001468492
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 261344466
STATE OF INCORPORATION: TX
FISCAL YEAR END: 0430
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-499091
FILM NUMBER: 231473003
BUSINESS ADDRESS:
STREET 1: 550 RESERVE ST, SUITE 360
CITY: SOUTHLAKE
STATE: TX
ZIP: 76092
BUSINESS PHONE: 682-237-7781
MAIL ADDRESS:
STREET 1: 550 RESERVE ST, SUITE 360
CITY: SOUTHLAKE
STATE: TX
ZIP: 76092
D
1
primary_doc.xml
X0708
D
LIVE
0001468492
Heart Test Laboratories, Inc.
550 RESERVE STREET
SUITE 360
SOUTHLAKE
TX
TEXAS
76092
(682) 237-7781
TEXAS
None
None
Corporation
true
Andrew
Simpson
550 Reserve Street
Suite 360
Southlake
TX
TEXAS
76092
Executive Officer
Director
Andrew Simpson is the President, Chief Executive Officer and Chairman of the Board of Directors.
Mark
Hilz
550 Reserve Street
Suite 360
Southlake
TX
TEXAS
76092
Executive Officer
Director
Mark Hilz is the Chief Operating Officer, Secretary and Director.
Danielle
Watson
550 Reserve Street
Suite 360
Southlake
TX
TEXAS
76092
Executive Officer
Danielle Watson is the Chief Financial Officer and Treasurer.
Bruce
Bent
550 Reserve Street
Suite 360
Southlake
TX
TEXAS
76092
Director
David
R.
Wells
550 Reserve Street
Suite 360
Southlake
TX
TEXAS
76092
Director
Brian
Szymczak
550 Reserve Street
Suite 360
Southlake
TX
TEXAS
76092
Director
Other Health Care
$1 - $1,000,000
- 06b
false
2023-11-16
false
true
true
false
0
934997
934997
0
Represents issuance of 4,854,853 shares of common stock, 710,605 pre-funded warrants and 914,148 warrants, in consideration of the right to commercialize a series of licenses, based on a closing price of $0.16 per share as of such issuance.
false
1
0
0
0
false
Heart Test Laboratories, Inc.
/s/ Andrew Simpson
Andrew Simpson
Chief Executive Officer
2023-12-07